4.7 Article

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine

期刊

BRAIN BEHAVIOR AND IMMUNITY
卷 30, 期 -, 页码 156-167

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2012.12.011

关键词

Schizophrenia; Social isolation rearing; Mitochondrial dysfunction; Tryptophan-kynurenine pathway; Adenosine triphosphate (ATP); Clozapine; N-acetyl cysteine; Dopamine; Immune-inflammatory; Animal model

资金

  1. South African Medical Research Council
  2. Janssen
  3. Lundbeck
  4. AstraZeneca
  5. NIH
  6. Cooperative Research Centre
  7. Simons Autism Foundation
  8. Cancer Council of Victoria
  9. Stanley Medical Research Foundation
  10. MBF
  11. NHMRC
  12. Beyond Blue
  13. Rotary Health
  14. Geelong Medical Research Foundation
  15. Bristol Myers Squibb
  16. Eli Lilly
  17. Glaxo SmithKline
  18. Organon
  19. Novartis
  20. Mayne Pharma
  21. Servier

向作者/读者索取更多资源

Apart from altered dopamine (DA) function, schizophrenia displays mitochondrial and immune-inflammatory abnormalities, evidenced by oxidative stress, altered kynurenine metabolism and cytokine release. N-acetyl cysteine (NAC), an antioxidant and glutamate modulator, is effective in the adjunctive treatment of schizophrenia. Social isolation rearing (SIR) in rats is a valid neurodevelopmental animal model of schizophrenia. This study evaluated whether SIR-induced behavioural deficits may be explained by altered plasma pro- and anti-inflammatory cytokines, kynurenine metabolism, and cortico-striatal DA and mitochondrial function (via adenosine triphosphate (ATP) release), and if clozapine or NAC (alone and in combination) reverses these changes. SIR induced pronounced deficits in social interactive behaviours, object recognition memory, and prepulse inhibition (PPI), while simultaneously increasing striatal but reducing frontal cortical accumulation of ATP as well as DA. SIR increased pro- vs. anti-inflammatory cytokine balance and altered kynurenine metabolism with a decrease in neuroprotective ratio. Clozapine (5 mg/kg/day x 14 days) as well as clozapine + NAC (5 mg/kg/day and 150 mg/kg/day x 14 days) reversed these changes, with NAC (150 mg/kg/day) alone significantly but partially effective in some parameters. Clozapine + NAC was more effective than clozapine alone in reversing SIR-induced PPI, mitochondrial, immune and DA changes. In conclusion, SIR induces mitochondrial and immune-inflammatory changes that underlie cortico-striatal DA perturbations and subsequent behavioural deficits, and responds to treatment with clozapine or NAC, with an additive effect following combination treatment. The data provides insight into the mechanisms that might underlie the utility of NAC as an adjunctive treatment in schizophrenia. (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychiatry

Depression, anxiety and worry in young Pacific adults in New Zealand during the COVID-19 pandemic

Richard J. Siegert, Ajit Narayanan, Joanna Dipnall, Lisa Gossage, Wendy Wrapson, Alexander Sumich, Fabrice Merien, Michael Berk, Janis Paterson, El-Shadan Tautolo

Summary: This study examined the symptoms of anxiety, depression, and hopelessness among young Pacific adults living in Auckland, New Zealand during the 2020/2021 COVID-19 pandemic and identified potential protective factors. The findings showed that approximately 25% of the participants scored in the moderate to severe range for anxiety, and 10% for depression. Additionally, around 40% of the sample reported finding the first lockdown very stressful. Self-compassion and Pacific Identity were moderately negatively correlated with anxiety, depression, hopelessness, and perceived stress.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2023)

Article Psychiatry

Personality traits as mediators of the relationship between childhood trauma and depression severity in bipolar disorder: A structural equation model

Anna L. Wrobel, Samantha E. Russell, Anuradhi Jayasinghe, Bianca E. Kavanagh, Mojtaba Lotfaliany, Alyna Turner, Olivia M. Dean, Sue M. Cotton, Claudia Diaz-Byrd, Anastasia K. Yocum, Elizabeth R. Duval, Tobin J. Ehrlich, David F. Marshall, Michael Berk, Melvin G. McInnis

Summary: This study found that personality traits may mediate the relationship between childhood trauma and the severity of bipolar depression; the indirect effect through neuroticism was significant in the mediation model. The results suggest that an individual's personality structure is an important factor to consider in therapeutic plans for individuals with bipolar disorder who have a history of childhood trauma.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2023)

Article Psychiatry

The effect of depressive symptoms on disability-free survival in healthy older adults: A prospective cohort study

Greg Roebuck, Mojtaba Lotfaliany, Bruno Agustini, Malcolm Forbes, Mohammadreza Mohebbi, John McNeil, Robyn L. Woods, Christopher M. Reid, Mark R. Nelson, Raj C. Shah, Joanne Ryan, Anne B. Newman, Alice Owen, Rosanne Freak-Poli, Nigel Stocks, Michael Berk

Summary: Late-life depression (LLD) may be a common and important risk factor for shortened healthspan. This study found that LLD was associated with lower disability-free survival in both female and male participants. Subthreshold depression was also associated with lower disability-free survival in both sexes.

ACTA PSYCHIATRICA SCANDINAVICA (2023)

Article Psychiatry

Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce

Wolfgang Marx, Sam H. Manger, Mark Blencowe, Greg Murray, Fiona Yan-Yee Ho, Sharon Lawn, James A. Blumenthal, Felipe Schuch, Brendon Stubbs, Anu Ruusunen, Hanna Demelash Desyibelew, Timothy G. Dinan, Felice Jacka, Arun Ravindran, Michael Berk, Adrienne O'Neil

Summary: This study aims to provide clinicians with evidence-based recommendations and implementation considerations for lifestyle-based mental health care for adults with Major Depressive Disorder (MDD). The study conducted systematic literature searches and formed nine recommendations, including physical activity, relaxation techniques, work-directed interventions, sleep, and mindfulness-based therapies. The study also emphasized the importance of implementing this approach with input from allied health professionals and support networks, and delivering interventions using a biopsychosocial-cultural framework.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2023)

Review Clinical Neurology

The concept of metabolic jet lag in the pathophysiology of bipolar disorder: implications for research and clinical care

Elena Koning, Alexandra McDonald, Alexander Bambokian, Fabiano A. Gomes, Jacob Vorstman, Michael Berk, Jennifer Fabe, Roger S. McIntyre, Roumen Milev, Rodrigo B. Mansur, Elisa Brietzke

Summary: Bipolar disorder (BD) is a chronic mental disorder characterized by depressive and manic episodes, circadian rhythm disruption, and changes in energetic metabolism. Metabolic jet lag is considered a core component of BD pathophysiology, associated with irregular eating rhythms and circadian desynchronization of energetic metabolism.

CNS SPECTRUMS (2023)

Article Substance Abuse

How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: Evidence from longitudinal panel data

Rebecca McKetin, Philip J. Clare, David Castle, Alyna Turner, Peter J. Kelly, Dan I. Lubman, Shalini Arunogiri, Victoria Manning, Michael Berk

Summary: This study aimed to determine whether the risk of psychotic symptoms during methamphetamine use was dependent on, increased by, or independent of having a family history of psychosis. The findings showed that both methamphetamine use and family history of psychosis were independently associated with psychotic symptoms in the past week, and the joint risk was even larger when they occurred together. There was no significant interaction between family history of psychosis and methamphetamine use in predicting psychotic symptoms, but family history of psychosis was an independent risk factor for the absolute risk of psychotic symptoms in this population.

ADDICTION (2023)

Editorial Material Geriatrics & Gerontology

Brain Health Is a Determinant of Mental Health

Harris A. Eyre, Robert Lundin, Veronica Podence Falcao, Michael Berk, Tadeusz Hawrot, Marion Leboyer, Frederic Destrebecq, Zoltan Sarnyai, Charles Reynolds, Helen Lavretsky, Kavitha Kolappa, Jeffrey Cummings

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Article Pharmacology & Pharmacy

Oxycodone-induced dopaminergic and respiratory effects are modulated by deep brain stimulation

Jason Yuen, Abhinav Goyal, Aaron E. Rusheen, Abbas Z. Kouzani, Michael Berk, Jee Hyun Kim, Susannah J. Tye, Osama A. Abulseoud, Tyler S. Oesterle, Charles D. Blaha, Kevin E. Bennet, Kendall H. Lee, Yoonbae Oh, Hojin Shin

Summary: Opioids are the leading cause of overdose death in the United States, with nearly 70,000 deaths in 2020. Deep brain stimulation (DBS) is a promising treatment for substance use disorders. This study investigated the modulation of dopaminergic and respiratory effects of oxycodone by DBS of the ventral segmental area (VTA) in rodents. The results demonstrated that DBS reduced baseline dopamine levels and alleviated the increase in dopamine levels and respiratory depression induced by oxycodone.

FRONTIERS IN PHARMACOLOGY (2023)

Article Neurosciences

The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial

Samantha E. Russell, David R. Skvarc, Mohammadreza Mohebbi, David Camfield, Linda K. Byrne, Alyna Turner, Melanie M. Ashton, Michael Berk, Seetal Dodd, Gin S. Malhi, Sue M. Cotton, Ashley I. Bush, Olivia M. Dean

Summary: N-acetylcysteine (NAC) is a therapeutic agent with multiple mechanisms of action in the central nervous system, and it has shown potential in reducing depressive symptoms in patients with major depressive disorder (MDD). A 12-week randomized controlled trial found no significant improvement at the primary endpoint but did see improvements at a later interview. The study also used a mixed methods approach to explore factors that may determine individual responses to NAC treatment.

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2023)

Review Biochemistry & Molecular Biology

Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine

Sourav Khanra, Preethi Reddy, Anna Gimenez-Palomo, Chun Hui J. Park, Bruna Panizzutti, Madeleine McCallum, Shyam Sundar Arumugham, Shreekantiah Umesh, Monojit Debnath, Basudeb Das, Ganesan Venkatasubramanian, Melanie Ashton, Alyna Turner, Olivia M. Dean, Ken Walder, Eduard Vieta, Lakshmi N. Yatham, Isabella Pacchiarotti, Y. C. Janardhan Reddy, Nishant Goyal, Muralidharan Kesavan, Lluc Colomer, Michael Berk, Jee Hyun Kim

Summary: The core feature of bipolar disorder is pathological disturbances in mood, along with disrupted thinking and behavior. Due to its complex and heterogeneous etiology, a range of genetic and environmental factors are involved. This complexity and poorly understood neurobiology make it challenging to develop drugs, resulting in limited treatment options, especially for bipolar depression. Therefore, novel approaches are needed, such as investigating the potential of trimetazidine as a treatment option for bipolar depression.

MOLECULAR PSYCHIATRY (2023)

Article Psychiatry

An Expert Roundtable Discussion on the Use of Classic Monoamine Oxidase Inhibitors in the Treatment of Depression-Part Two

Michael Berk, Vincent Van den Eynde, Karthikeyan Ganapathy, Chittaranjan Andrade, Tom Birkenhager, J. Alexander Bodkin, David Nutt, Brian Barnett, Simeon Shalom Feinberg, Gordon Parker, Eric Ruhe, Michele Fornaro, Charles Redhead, Lila Godet, Peter Kenneth Gillman

Summary: Experienced clinicians and academics from the International MAOI Expert Group provide comments on the use of monoamine oxidase inhibitor (MAOI) pharmacotherapy for depression. They emphasize the importance of good pharmacological practice, starting with a low dose and making changes slowly and gradually. The comments also discuss issues related to augmentation and drug combinations, and highlight the unique ability of MAOIs to improve dopamine function.

PSYCHIATRIC ANNALS (2023)

Article Psychology, Clinical

Evaluating the acceptability of ATMAN intervention for self-harm in youth in India: A pilot study

Shilpa Aggarwal, Michael Berk, Nilesh Shah, Anokhi Shah, Dimple Kondal, George Patton, Vikram Patel

Summary: ATMAN, a contextually adapted psychological intervention developed in India, was delivered to a group of young people who self-harm. The results showed that ATMAN was acceptable and led to significant improvements in psychological measures. This suggests that ATMAN has the potential to be implemented at all levels of healthcare settings to reduce the burden of suicide in young people. However, further randomized controlled trials are needed to identify key competencies for training and supervision, as well as quality assurance measures for effective implementation of ATMAN.

INTERNATIONAL JOURNAL OF MENTAL HEALTH (2023)

Meeting Abstract Clinical Neurology

Diet, nutrition, and eating behaviors in bipolar disorder: A narrative review from the ISBD nutrition and exercise task force (NEXT)

Elisa Brietzke, Elena Koning, Mohammad Alsuwaidan, Vicent Balanza-Martinez, Michael Berk, Jess Fiedorowicz, Mark Frye, Manuel Gardea-Resendez, Fabiano Gomes, Ana Gonzalez-Pinto, Rodrigo Mansur, Wolfgang Marx, Roumen Milev, Lucas Neves, Andrew Nierenberg, Andrew Olagunju, Gayatri Saraf, Marco Solmi, Beny Lafer

BIPOLAR DISORDERS (2023)

Meeting Abstract Clinical Neurology

Nutrition and bipolar disorder: A systematic review

Fernanda Carramaschi Gabriel, Michael Berk, Elisa Brietzke, Felice Jacka, Beny Lafer

BIPOLAR DISORDERS (2023)

Meeting Abstract Clinical Neurology

Differential associations of mentally-active and passive sedentary behaviours and physical activity with putative cognitive decline in bipolar disorder: Findings from the UK biobank cohort

Elysha Ringin, David Dunstan, Roger S. McIntyre, Neville Owen, Michael Berk, Susan Rossell, Mats Hallgren, Tamsyn Van Rheenen

BIPOLAR DISORDERS (2023)

Letter Immunology

Reply to letter by Dr. Fu and Dr. Chu: Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders

Wan-Ju Cheng, Hong-Mo Shih, Kuan-Pin Su, Po-Ren Hsueh

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for COVID-19 in Brazil

Felipe Kenji Sudo, Talita P. Pinto, Fernanda G. Q. Barros-Aragao, Ivanei Bramati, Theo F. Marins, Marina Monteiro, Fernanda Meireles, Rejane Soares, Pilar Erthal, Victor Calil, Naima Assuncao, Natalia Oliveira, Joana Bondarovsky, Camila Lima, Beatriz Chagas, Alana Batista, Julia Lins, Thais L. Pinheiro, Felippe Mendonca, Andrea Silveira de Souza, Fernanda C. Rodrigues, Gabriel R. de Freitas, Pedro Kurtz, Paulo Mattos, Erika C. Rodrigues, Fernanda G. De Felice, Fernanda Tovar-Moll

Summary: Post-COVID-19 Condition (PCC) is a multisystemic syndrome that persists for months after SARS-CoV-2 infection, affecting cognitive function and neuropsychiatric features. A study on COVID-19 survivors in Brazil found that these patients experienced significant difficulties in overall cognition, memory, working memory, and inhibitory control, as well as fatigue, anxiety, and depressive symptoms. In addition, elevated levels of inflammatory markers in the blood were associated with brain microstructural damage and cognitive impairments.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Chemogenetic approaches reveal dual functions of microglia in seizures

Aastha Dheer, Dale B. Bosco, Jiaying Zheng, Lingxiao Wang, Shunyi Zhao, Koichiro Haruwaka, Min-Hee Yi, Abhijeet Barath, Dai-Shi Tian, Long-Jun Wu

Summary: Microglial activation plays a crucial role in the pathology of epilepsy, with both acute and prolonged activation affecting seizure severity and neuronal loss.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Maternal inflammation during pregnancy is associated with risk of ADHD in children at age 10

Julie B. Rosenberg, Jens Richardt Mollegaard Jepsen, Parisa Mohammadzadeh, Astrid Sevelsted, Rebecca Vinding, Mikkel E. Sorensen, David Horner, Kristina Aagaard, Birgitte Fagerlund, Susanne Brix, Nilofar Folsgaard, Ann -Marie M. Schoos, Jakob Stokholm, Bo Chawes, Christos Pantelis, Soren Dalsgaard, Birte Y. Glenthoj, Niels Bilenberg, Klaus Bonnelykke, Bjorn H. Ebdrup

Summary: Clinical data demonstrates a strong association between prenatal maternal inflammation assessed by hs-CRP and a diagnosis of ADHD by age 10. Maternal inflammation is also associated with ADHD symptom load in the entire cohort.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Voluntary wheel running prevents formation of membrane attack complexes and myelin degradation after peripheral nerve injury

Suzanne M. Green-Fulgham, Michael J. Lacagnina, Kendal F. Willcox, Jiahe Li, Michael E. Harland, Adriano Polican Ciena, Igor R. Correia Rocha, Jayson B. Ball, Renee A. Dreher, Younus A. Zuberi, Joseph M. Dragavon, Marucia Chacur, Steven F. Maier, Linda R. Watkins, Peter M. Grace

Summary: Regular aerobic activity, specifically voluntary wheel running, can reduce the risk of chronic pain by inhibiting MAC and preserving myelin integrity at the site of peripheral nerve injury.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Neuronanomedicine for Alzheimer's and Parkinson's disease: Current progress and a guide to improve clinical translation

India Boyton, Stella M. Valenzuela, Lyndsey E. Collins-Praino, Andrew Care

Summary: Neuronanomedicine is a multidisciplinary field that aims to develop innovative nanotechnologies for the treatment of neurodegenerative disorders. Nanoparticles are an important component of neuronanomedicine, as they can improve drug properties and enhance safety and delivery across the blood-brain barrier. However, a major challenge for neuronanomedicine translation is the poor understanding of bio-nano interactions, partly due to inconsistent reporting in published works. This review provides specific recommendations to guide researchers in harnessing the unique properties of nanoparticles for breakthrough treatments of Alzheimer's and Parkinson's disease.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Mind versus body: Perceived stress and biological stress are independently related to cognitive decline

Celine De Looze, Cathal McCrory, Aisling O'Halloran, Silvia Polidoro, Rose Anne Kenny, Joanne Feeney

Summary: Our study found that subjective measures of stress and biological metrics may be independently associated with cognitive function over time in older adults, hinting at potential different underlying mechanisms.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Choroid plexus volume is increased in mood disorders and associates with circulating inflammatory cytokines

Beatrice Bravi, Elisa Maria Teresa Melloni, Marco Paolini, Mariagrazia Palladini, Federico Calesella, Laura Servidio, Elena Agnoletto, Sara Poletti, Cristina Lorenzi, Cristina Colombo, Francesco Benedetti

Summary: Depressed patients show changes in immune-inflammatory markers in their blood and cerebrospinal fluid. The Choroid Plexus, located at the base of the brain ventricles, plays a key role in regulating the exchange of substances between the brain and immune cells. Patients with bipolar disorder or major depressive disorder have larger Choroid Plexus volumes compared to healthy controls. Age and levels of circulating cytokines are associated with Choroid Plexus volumes in the clinical groups.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Probiotic Clostridium butyricum ameliorates cognitive impairment in obesity via the microbiota-gut-brain axis

Mingxuan Zheng, Huaiyu Ye, Xiaoying Yang, Lijun Shen, Xuemei Dang, Xiaoli Liu, Yuying Gong, Qingyuan Wu, Li Wang, Xing Ge, Xiaoli Fang, Benchi Hou, Peng Zhang, Renxian Tang, Kuiyang Zheng, Xu-Feng Huang, Yinghua Yu

Summary: Obesity is linked to cognitive dysfunction and neurodegenerative disease. The connection between the gut microbiota and the brain is altered in obesity. The probiotic Clostridium butyricum can improve cognitive impairment caused by obesity and prevent gut microbiota dysbiosis and inflammation.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Stem-cell derived neurosphere assay highlights the effects of viral infection on human cortical development

Edward Drydale, Phalguni Rath, Katie Holden, Gregory Holt, Laurissa Havins, Thomas Johnson, James Bancroft, Lahiru Handunnetthi

Summary: This study created a novel three-dimensional neurosphere assay using induced pluripotent stem cell differentiation and live cell imaging techniques to investigate the effect of a simulated viral infection on cortical development. The findings demonstrated that the infection led to reduced radial glial growth and neural migration.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

An integral blood-brain barrier in adulthood relies on microglia-derived PDGFB

Yuancheng Weng, Ningting Chen, Rui Zhang, Jian He, Xukai Ding, Guo Cheng, Qianqian Bi, Ying-mei Lu, Xiao Z. Shen, Shu Wan, Peng Shi

Summary: This study reveals that microglia is the primary cellular source of PDGFB in adults, and microglial PDGFB is crucial for maintaining BBB integrity in adult mice.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Gonadal hormones impart male-biased behavioral vulnerabilities to immune activation via microglial mitochondrial function

Evan A. Bordt, Haley A. Moya, Young Chan Jo, Caitlin T. Ravichandran, Izabella M. Bankowski, Alexis M. Ceasrine, Christopher J. Mcdougle, William A. Carlezon Jr, Staci D. Bilbo

Summary: There is a strong male bias in many neurodevelopmental disorders such as autism spectrum disorder, but the mechanisms behind this bias are unknown. Infection during the perinatal period increases the risk of neurodevelopmental disorders. Using a mouse model, researchers found that early-life immune activation only induced deficits in social behaviors in male mice. These behavioral changes were associated with alterations in microglial immune signaling, mitochondrial morphology, gene expression, and function specifically in microglia, the brain's innate immune cells. Furthermore, the vulnerability to early-life immune activation and its effects on behavior and microglial mitochondria were programmed by the male-typical perinatal gonadal hormone surge. These findings highlight the role of microglia-specific mechanisms shaped by early developmental events in regulating male social behavior throughout lifespan.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Interleukin-15 alters hippocampal synaptic transmission and impairs episodic memory formation in mice

Maria Amalia Di Castro, Stefano Garofalo, Alessandro Mormino, Laura Carbonari, Erika Di Pietro, Eleonora De Felice, Myriam Catalano, Laura Maggi, Cristina Limatola

Summary: Cytokines, such as interleukin-15 (IL-15), play important roles in modulating the central nervous system (CNS). In this study, the authors found that exposure to IL-15 enhances GABA release and reduces glutamatergic currents in hippocampal slices. Chronic treatment with IL-15 has negative effects on memory formation. Serotonin is involved in mediating these effects, as a selective 5-HT3A receptor antagonist prevents the effects on inhibitory neurotransmission and improves performance in a memory test.

BRAIN BEHAVIOR AND IMMUNITY (2024)

Article Immunology

Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling

Nikhitha Sreenivas, Michael Maes, Hansashree Padmanabha, Apoorva Dharmendra, Priyanka Chakkera, Saptamita Paul Choudhury, Fazal Abdul, Thrinath Mullapudi, Vykuntaraju K. Gowda, Michael Berk, John Vijay Sagar Kommu, Monojit Debnath

Summary: Neurodevelopmental disorders (NDDs) are a spectrum of conditions with both common and differing characteristics in terms of phenome, symptomatome, neuropathology, risk factors and underlying mechanisms. This study investigates the possibility of a shared immune etiology among three early-onset NDDs, namely Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD) and Intellectual Disability Disorder (IDD).

BRAIN BEHAVIOR AND IMMUNITY (2024)